01 August 2005
Effect of pyrimethamine in experimental rheumatoid arthritis.
Farshid Saadat, Salvatore Cuzzocrea, Rosanna Di Paola, Mohammad Pezeshki, Mohammad Khorramizadeh, Mohammad Sedaghat, Alireza Razavi, Abbas MirshafieyMed Sci Monit 2005; 11(8): BR293-299 :: ID: 201062
Abstract
Background: Recent evidence has shown that the antimalarials are usefuldrugs in the treatment of various rheumatic diseases. The present study was designed to test the therapeuticeffect of pyrimethamine (PYR) in collagen-induced arthritis (CIA). Material/Methods: CIA was inducedin Lewis rats. The intraperitoneal administration of PYR and methotrexate (MTX) were started on day 25post-immunization and continued until final assessment on day 35. During this period, clinical examinationwas performed intermittently. Anti-C II Ab and nitric oxide (NO) synthesis were measured. The paws andknees were then removed for histopathology and radiography assay. The biocompatibility of PYR and MTXwere assessed using a fibrosarcoma cell line. Results: Data showed that i.p. injection of pyrimethamineto arthritic rats induced a significant reduction in paw edema. This beneficial effect was associatedwith a significant decrease in anti-CII antibody response compared with untreated rats. Histopathologicalassessment showed reduced inflammatory cell infiltrate in the joints of treated rats, and tissue edemaand bone erosion in the paws were markedly reduced following PYR therapy. Moreover, our radiography resultsparalleled our histological findings. Cytotoxicity analysis of PYR showed greater tolerability comparedwith MTX. Treatment with PYR significantly diminished nitric oxide formation in treated rats comparedwith untreated controls. Conclusions: Our findings shed light on the therapeutic efficacy of pyrimethaminein experimental rheumatoid arthritis compared with a choice drug (methotrexate), which may recommendedit as a second-line drug in the treatment of rheumatoid arthritis.
Keywords: Arthritis, Experimental - radiography, Antibodies - immunology, Arthritis, Experimental - radiography, Arthritis, Rheumatoid - radiography, Cell Line, Cell Survival - drug effects, Matrix Metalloproteinase 2 - metabolism, Nitric Oxide - blood, Pyrimethamine - therapeutic use, Rats, Inbred Lew
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
15 Apr 2024 : Laboratory Research
The Role of Copper-Induced M2 Macrophage Polarization in Protecting Cartilage Matrix in OsteoarthritisMed Sci Monit In Press; DOI: 10.12659/MSM.943738
07 Mar 2024 : Clinical Research
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...Med Sci Monit In Press; DOI: 10.12659/MSM.943468
08 Mar 2024 : Animal Research
Modification of Experimental Model of Necrotizing Enterocolitis (NEC) in Rat Pups by Single Exposure to Hyp...Med Sci Monit In Press; DOI: 10.12659/MSM.943443
18 Apr 2024 : Clinical Research
Comparative Analysis of Open and Closed Sphincterotomy for the Treatment of Chronic Anal Fissure: Safety an...Med Sci Monit In Press; DOI: 10.12659/MSM.944127
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952